STRS Ohio’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

STRS Ohio’s Portfolio ARIA Stock Details ARIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-8,200	Closed	-$102K	–	1993
2016 Q4	$102K	Sell	8,200 -8,400	-51%	-$101K	﹤0.01%	1649
2016 Q3	$227K	Buy	+16,600	New	+$167K	﹤0.01%	1525
2014 Q4	–	Sell	-4,000	Closed	-$22K	–	1870
2014 Q3	$22K	Buy	+4,000	New	+$23.4K	﹤0.01%	1729
2013 Q4	–	Sell	-110,000	Closed	-$2.02M	–	1886
2013 Q3	$2.02M	Buy	+110,000	New	+$2.14M	0.01%	565

Other funds holding ARIA

FPF

FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

STRS Ohio's ARIA Position: Q1 2017 in Review

STRS Ohio sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2017, closing a stake of 8,200 shares — an estimated $102K sold.

STRS Ohio first reported a position in ARIA in Q3 2013 and held it in 4 quarters. The position peaked at $2.02M in Q3 2013. 1 fund tracked by Wall St. Rank holds ARIA as of Q1 2017.

STRS Ohio reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2017 after selling out during the quarter.
STRS Ohio sold 8,200 Ariad Pharmaceuticals Inc shares in Q1 2017, an estimated $102K.
STRS Ohio first reported a position in Ariad Pharmaceuticals Inc in Q3 2013 and held it in 4 quarters.
STRS Ohio's Ariad Pharmaceuticals Inc position peaked at $2.02M in Q3 2013.
1 fund tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2017.

Based on STRS Ohio's 13F filing for Q1 2017, filed 26 Apr 2017.